Nosocomial Infections Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Nosocomial Infections Market size was valued at USD 4,281.1 billion in 2021 and is expected to grow at a CAGR of 8.1% from 2022-2028. Nosocomial infections also referred to as healthcare-acquired infections (HAI), these infections are caused by bacteria, viruses, or fungi. Many infections can be acquired in clinical settings such as nursing homes, rehabilitation centers outpatient clinics, or other therapeutic settings. This can be obtained via an infected patient, the outside environment, or the facility’s staff. Infections acquired in the hospital pose a danger to all patients. Hospital-acquired infections are more common in surgical patients, the elderly, and children. Among the most common infections include respiratory infections, surgical-site infections, gastrointestinal infections, urinary tract infections, bloodstream infections, cardiovascular drugs system infections, and bone and joint infections. Hospital-acquired diseases occur throughout the world, affecting both developed and developing countries, and are major causes of death among hospitalized patients. Furthermore, The rising number of nosocomial infection patients, the government’s increasing number of regulations penalizing hospitals, extended hospitalization and antibody resistance, the growth of the medical tourism industry, and the prevalence of modernized healthcare infrastructure are some of the major and impactful factors that will likely drive the growth of the nosocomial infection market during the forecast period of. On the other hand, the advancement of various technologies and the increased number of research and development activities by various firms will create several chances, resulting in the expansion of the nosocomial infection market during the forecast period. However, one major impediment to the global market is a lack of awareness about nosocomial infections in low and middle-income countries. The market is primarily driven by an increase in the number of illnesses occurring in healthcare settings, particularly in developing nations with inadequate hygiene facilities. However, throughout the hospital-acquired infection diagnostics market projection, the drop in hospital-acquired infections in developed nations such as the United States, Germany, and the United Kingdom impedes the growth of the hospital-acquired infection diagnostics market.

Key Developments:

In 2021, STERIS acquired Cantel, a global provider of infection prevention products and services, through a US subsidiary, to diversify its vast portfolio of sterilization services.